
Opinion|Videos|August 16, 2023
Emerging Therapies for Dry Eye Disease
Crystal Brimer, OD, and Kelly K. Nichols, OD, MPH, PhD, discuss two treatments, AZR-MD-001 and Reproxalap, that are in the pipeline to treat patients with dry eye disease (DED).
Advertisement
Episodes in this series

Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
STAAR Surgical terminates proposed acquisition by Alcon
2
Innovations in glaucoma poised for breakthrough in 2026 (and what might hold them back)
3
Rates of retinal layer thinning predict visual field progression in glaucoma
4
FDA Clears IND application for GenEditBio’s GEB-101 in TGFBI corneal dystrophy
5


























































